The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 8,736 767,026 SH   SOLE   767,026 0 0
FATE THERAPEUTICS INC COM 31189P102 1,122 72,273 SH   SOLE   72,273 0 0
GALAPAGOS NV SPON ADR 36315X101 8,677 56,840 SH   SOLE   56,840 0 0
MERUS N V COM N5749R100 18,510 1,038,746 SH   SOLE   1,038,746 0 0
PIERIS PHARMACEUTICALS INC COM 720795103 10,088 2,958,243 SH   SOLE   2,958,243 0 0
PROQR THRAPEUTICS N V SHS EURO N71542109 4,790 831,661 SH   SOLE   831,661 0 0
SPDR SERIES TRUST S&P BIOTECH 78464A870 38,125 500,000 SH Put SOLE   0 0 500,000
SPERO THERAPEUTICS INC COM 84833T103 12,236 1,154,356 SH   SOLE   1,154,356 0 0
UNIQURE NV SHS N90064101 15,398 391,199 SH   SOLE   391,199 0 0
UNIQURE NV SHS N90064101 15,744 400,000 SH Call SOLE   0 0 400,000
XENON PHARMACEUTICALS INC COM 98420N105 8,573 951,527 SH   SOLE   951,527 0 0